NCT07306689 Posttraumatic Stress Disorder in Ectopic Pregnancy
| NCT ID | NCT07306689 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jagiellonian University |
| Condition | Ectopic Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-12-15 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to prospectively assess the prevalence of post-traumatic stress disorder (PTSD) symptoms in a population of women who have experienced a diagnosis of ectopic pregnancy. The investigation into the prevalence of PTSD symptoms will aid in better identifying women who may benefit from early psychological intervention.
Eligibility Criteria
Inclusion Criteria: * ectopic pregnancy * gestational age up to 14 weeks. Exclusion Criteria: * heterotopic pregnancy
Contact & Investigator
Iwona Gawron, PhD, MD
STUDY DIRECTOR
Jagiellonian University
Frequently Asked Questions
Who can join the NCT07306689 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Ectopic Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07306689 currently recruiting?
Yes, NCT07306689 is actively recruiting participants. Contact the research team at iwona.gawron@uj.edu.pl for enrollment information.
Where is the NCT07306689 trial being conducted?
This trial is being conducted at Krakow, Poland, Krakow, Poland.
Who is sponsoring the NCT07306689 clinical trial?
NCT07306689 is sponsored by Jagiellonian University. The principal investigator is Iwona Gawron, PhD, MD at Jagiellonian University. The trial plans to enroll 200 participants.